Frequency of β-Blocker Use Following Exacerbations of COPD in Patients with Compelling Indication for Use
- 1 November 2019
- journal article
- research article
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 112 (11), 586-590
- https://doi.org/10.14423/smj.0000000000001038
Abstract
Objective: To assess the current use of β-blockers in patients with compelling indications for use, following the acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods: We performed a multicenter retrospective observational study using data from all of the patients admitted to five institutions for an acute exacerbation of COPD. Patients were included if they were...Keywords
This publication has 30 references indexed in Scilit:
- Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: Findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION)American Heart Journal, 2013
- Beta-blocker use and COPD mortality: a systematic review and meta-analysisBMC Pulmonary Medicine, 2012
- The Impact of COPD on Management and Outcomes of Patients Hospitalized With Acute Myocardial Infarction: A 10-Year Retrospective Observational StudySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Effect of blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ, 2011
- HFSA 2010 Comprehensive Heart Failure Practice GuidelineJournal of Cardiac Failure, 2010
- β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary DiseaseArchives of Internal Medicine, 2010
- Cardio‐selective and non‐selective beta‐blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exerciseInternal Medicine Journal, 2010
- Use of blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax, 2008
- Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary diseaseQJM: An International Journal of Medicine, 2005
- Beta blockers prevent cardiac death following a myocardial infarction: So why are so many infarct survivors discharged without beta blockers?The American Journal of Cardiology, 1996